A detailed history of High Tower Advisors, LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 8,745 shares of MDXG stock, worth $79,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,745
Previous 8,245 6.06%
Holding current value
$79,492
Previous $57,000 10.53%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.65 - $7.76 $2,825 - $3,880
500 Added 6.06%
8,745 $51,000
Q2 2024

Aug 13, 2024

BUY
$6.16 - $8.08 $50,789 - $66,619
8,245 New
8,245 $57,000
Q4 2023

Feb 12, 2024

BUY
$5.7 - $9.14 $79,041 - $126,744
13,867 New
13,867 $121,000
Q2 2021

Aug 06, 2021

SELL
$9.02 - $12.72 $299,464 - $422,304
-33,200 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$8.48 - $11.28 $55,120 - $73,320
-6,500 Reduced 16.37%
33,200 $342,000
Q4 2020

Feb 10, 2021

BUY
$5.32 - $10.17 $211,204 - $403,749
39,700 New
39,700 $360,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.03B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.